NTUitive_WhyStartUp___1400x365___1400x365.jpg

Peregrine Ophthalmic Pte Ltd

Biomedical & Healthcare

PeregrineOpthalmic.png
PeregrineOpthalmic.png

Company Overview

Peregrine Ophthalmic produces Liposomal latanoprost, which is a sustained release product of latanoprost for the medical treatment of glaucoma.
Liposomal latanoprost is easily delivered in the clinic by the ophthalmologist, and is extremely well tolerated by patients.

Features

1. Has obtained FDA approval to conduct clinical trials in USA.
2. Phase 2 multi-centre clinical trials are now underway.